Q4
Q4 Inc. (TSX: QFOR), a leading capital markets communications platform, today announced the appointment of Donna de Winter as chief financial officer (CFO) effective August 8, 2022. Ms. de Winter has been serving as interim CFO since May 31, 2022.
“On behalf of the Q4 Board and the entire Q4 team, we are thrilled to announce that Donna has assumed the role of CFO, after serving in an interim capacity for the last few months,” said Darrell Heaps, CEO. “We are incredibly fortunate to benefit from Donna’s breadth of industry expertise across finance, strategy and operations. Donna has added tremendous value to Q4 over the last few years as Chief Operating Officer, and her lens of operational knowledge along with her strong background as a financial leader of both private and publicly traded companies brings a powerful combination and perspective to the CFO role. We look forward to benefiting from Donna’s deep bench of experience as we pursue our strategic vision and path to profitability.”
“I am excited to add to my role at Q4, bringing forward the financial expertise I’ve accumulated over the course of my career to further contribute to the growth and success of the company,” said Ms. de Winter. “Q4 has unique strengths, a strong business model and a tremendous opportunity ahead of it. I look forward to sharpening my focus on driving more efficient growth as we deliver a premium experience for our customers and enhance value for all stakeholders.”
Donna de Winter joined Q4 in January 2019 as Q4’s Chief Operating Officer. She brings over 20 years of financial leadership across the technology sector. Prior to joining Q4, Ms. de Winter served as the CFO of Vision Critical, now Alida, and CFO of Varicent, where she led the company’s sale to IBM. Additionally, Ms. de Winter serves as a board member of Tealbook, a Toronto-based technology company. Donna received her Master’s in Business Administration from the University of Toronto.
About Q4 Inc .
Q4 Inc. (TSX: QFOR) is a leading capital markets communications platform that is transforming the way publicly traded companies, investors and investment banks make decisions to efficiently discover, communicate and engage with each other. The Q4 end-to-end technology platform facilitates interactions across the capital markets through its IR website products, virtual events solutions, capital markets CRM, shareholder and market analytics tools. The firm is a trusted partner to more than 2,650 public companies globally including many of the most respected brands in the world. Q4 is based in Toronto, with offices in New York and London. Learn more at q4inc.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005341/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KRAFTON Achieves Record-High Quarterly Sales in Q1 202529.4.2025 09:00:00 CEST | Press release
Thanks to PUBG IP expansion, inZOI’s strong debut, and BGMI’s global growth, quarter-over-quarter sales are up 41.6%, while operating profit is up 112.2% KRAFTON, Inc. today announced its first quarter earnings results for 2025. Based on consolidated financial statements prepared in accordance with Korean International Financial Reporting Standards (K-IFRS), the company achieved a record-high quarterly sales performance of 874.2B KRW and operating profit of 457.3B KRW. In addition to high quarter-over-quarter growth, year-over-year growth has also set records with sales up by 31.3% and operating profit upby 47.3%. Significant Growth and Core IP Direction KRAFTON achieved significant growth across all of its business divisions, including PC (323.5B KRW), mobile (532.4B KRW), and console/others (18.3B KRW). On PC platforms, PUBG: BATTLEGROUNDS’ diversified content and strong live-service operations contributed significantly to growth while the successful launch of a new IP, inZOI, also p
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform29.4.2025 09:00:00 CEST | Press release
Industry veteran Robert J. Dempsey Appointed Chairman of the Board to Guide Strategic Growth in Europe and the U.S. Azalea (A-zuh-lay-ah)Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appointment of Robert J. Dempsey as Chairman of the Board to guide strategic growth in the European and U.S. markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429247873/en/ Robert Dempsey, Chairman of the Board, Azalea Vision "Strong participation from repeat investors in this Series A milestone reaffirms their trust in our medical device and innovation for the future of intelligent ocular health,” said Enrique Vega, CEO of Azalea Vision. “Additional funding in this round from SPRIM Global Investments and Afrimobility, along with a strategic investor who remains undisclosed, further emphasizes the confidence in
A Third of Global CIOs Warn of Unrealistic Board Expectations as The World Bets Big on AI, According to Expereo29.4.2025 09:00:00 CEST | Press release
A new survey commissioned by Expereo exposes the true roadblocks to global AI plans - poor infrastructure, resistance from employees, unreasonable demands A third of global technology leaders believe their board has unrealistic expectations or demands on how new technologies like AI will impact business performance. This is according to an IDC InfoBrief*, commissioned by Expereo, which highlights serious roadblocks to global AI implementation, despite AI being considered critical to fulfilling business priorities. The research of 650 technology leaders in global organizations across Europe, the US and APAC reveals that 34% of global technology leaders have been forced to reassess their technology infrastructure because of rising geopolitical risks, as 37% say geopolitical disruptions are currently impacting their organization’s growth strategies. Amid the volatile economic backdrop, it seems most organizations are placing their bets on AI to drive growth. The research shows that 87% of
Cyber Guru Named Winner of the Coveted Global InfoSec Awards during RSA Conference 202529.4.2025 09:00:00 CEST | Press release
Cyber Guru Wins Hot Company in Security Awareness Training in the 13th Annual Global InfoSec Awards at #RSAC 2025 Cyber Guru, the leading cybersecurity awareness training platform, is proud to announce we have won the “Hot Company - Security Awareness Training” award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429950821/en/ Cyber Guru, Global InfoSec Award Winner 2025 “We’re thrilled to receive one of the most prestigious and coveted cybersecurity awards in the world from Cyber Defense Magazine, during their 13th anniversary as one of the world’s leading independent cybersecurity news and information provider. We knew the competition would be tough and with top judges who are leading infosec experts from around the globe, we couldn’t be more pleased,” said Gianni Baroni, CEO and founder of Cyber Guru. Cyber Guru embodies
Microba Delivers Landmark IBD Results & Signs Major Gastro Partner29.4.2025 07:52:00 CEST | Press release
Two independent clinical studies have demonstrated that Microba’s MetaPanel™ test identifies gastrointestinal pathogens in >35% of Inflammatory Bowel Disease (IBD) patients experiencing flare, with >60% of these missed by current routine testing methods.These findings have the potential to shift treatment protocols and provide a new path to remission for IBD patients, avoiding unnecessary therapy escalation or surgery.Microba partners with Colonoscopy Clinic and Integrated Gut Health, one of Australia’s largest private gastroenterology services, to embed microbial diagnostic testing into routine care to improve patient outcomes. Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant developments: the release of new clinical utility results for its MetaPanel™ gastrointestinal pathogen test, and the signing of a strategic clinical partnership with the Colonoscopy Clinic, and its wholly owned partner, Integrated Gut Health, one
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom